To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC3753 | Nsc-24198 |
Novel potent SHP2 Inhibitor with Anti-Proliferative Activity in Breast Cancer Cell Lines
More description
|
|
| DCC3752 | Nsc24048 |
Novel inhibitor of ABCG2 transporter function
More description
|
|
| DCC3751 | nsc-20596 |
Capturer of kinase-insertion domain receptor (KDR) from a solution, while allowing the captured KDR to bind with the solution-phase vascular endothelial growth factor (VEGF)
More description
|
|
| DCC3750 | Nsc-18725 |
Novel inhibitor of growth of intracellular Mycobacterium tuberculosis, inducing autophagy in differentiated THP-1 macrophages
More description
|
|
| DCC3749 | Nsc-176377 |
Non-nucleoside reverse transcriptase inhibitor
More description
|
|
| DCC3748 | nsc-176327 |
Selective G-quadruplex inducer of the human telomeric sequence; Stabilizer of the G-quadruplex formed by the MYC promoter sequence; Anti-neoplastic effects in wild-type p53, p53-mutant or p53-deficient human colon cancer cells.
More description
|
|
| DCC3747 | Nsc175176 |
Novel potent and selective serotonin reuptake inhibitor (SSRI)
More description
|
|
| DCC3746 | Nsc16168 |
Specific inhibitor of ERCC1-XPF with no effect on both HhaI and XPG
More description
|
|
| DCC3745 | Nsc-140873 |
Inhibitor of the RUNX1-CBFβ interaction
More description
|
|
| DCC3744 | Nsc13987 |
Novel inhibitor of Nef-calnexin interaction
More description
|
|
| DCC3743 | Nsc-134754 |
HIF-pathway inhibitor
More description
|
|
| DCC3742 | Nsc-13030 |
Novel potent SHP2 Inhibitor with Anti-Proliferative Activity in Breast Cancer Cell Lines
More description
|
|
| DCC3741 | Nsc127133 |
Novel inhibitor of the second bromodomain (BD2) of the BET family protein BRD2
More description
|
|
| DCC3740 | Nsc-126188 |
Apoptosis inducer; Antitumor agent
More description
|
|
| DCC3739 | Nsc-12404 |
Selective non-lipid agonist of LPA2/3
More description
|
|
| DCC3738 | Nsc-117199 |
Selective inhibitor of shp2 protein tyrosine phosphatase (PTP)
More description
|
|
| DCC3737 | Nsc114792 |
Novel selective inhibitor of JAK3
More description
|
|
| DCC3736 | Nsc109779 |
Novel potent inhibitor of Huntington's disease (HD) pathogenesis via targeting CAG repeats RNA and Poly Q protein
More description
|
|
| DCC3735 | Nsc109131 |
Inhibitor of human tyrosyl-DNA phosphodiesterase 1 (TDP1)
More description
|
|
| DCC3734 | Nsc107392 |
Novel substrate of ABCG2
More description
|
|
| DCC3733 | Nsc-104999 |
Ligand of the Grb7 SH2 domain, inhibiting the growth of MDA-MB-468 cancer cells
More description
|
|
| DCC3732 | Nsc103054 |
Novel inhibitor of ABCG2 transporter function
More description
|
|
| DCC3731 | Nsc1011 |
Ras converting enzyme 1 (Rce1) inhibitor
More description
|
|
| DCC3730 | Nsc-100874 |
Novel antagonist of the Grb7 SH2 domain; Antitumor Agent
More description
|
|
| DCC3729 | Nsc1008 |
Novel Inhibitor of the Ras Converting Enzyme 1 (Rce1) Protease, Disrupting Ras Membrane Localization in Human Cells
More description
|
|
| DCC3728 | Nsc10010 |
Novel potent growth inhibitor for gammaherpesvirus-associated B-lymphomas through activation of both the NF-κB and c-Myc-mediated signaling pathways
More description
|
|
| DCC3727 | Ns-6784 Hydrochloride |
Novel α7 nAChR agonist at human and rat receptors
More description
|
|
| DCC3726 | Ns-6740 |
Novel potent α7 nAChR partial agonist
More description
|
|
| DCC3725 | Ns4591 |
Novel molulator of SK-IK channels [small- and intermediate-conductance Ca2(+) -activated K(+) channels]
More description
|
|
| DCC3724 | ns3-in-5 |
Novel allosteric inhibitor of HCV NS3 protein function
More description
|
|